Europe Protein Expression Market

Europe Protein Expression Market Size (2024 to 2029)

The size of the Protein Expression Market in Europe was worth USD 748.85 Million in 2024. This value is estimated to be growing at a CAGR of 4.3% to reach USD 923.05 Million by 2029. Europe was the second-largest region in the global market in 2023.

Wide usage of protein expression for a variety of applications is estimated to drive the European market. R&D movement in the pharma sector and improved prospects in proteomics and Y-O-Y growth in the cancer incidence are acting as supporting factors to the market growth. The growing baby-boomer population is more likely to diagnose chronic diseases, which is estimated to favor the protein expression market in Europe.

However, issues such as high product expansion costs and strict Regulatory Environment in the EU are restraining the growth of the market in this part of the world.

This research report on the Europe Protein Expression Market has been segmented and sub-segmented into the following categories:

• By Expression Systems: Yeast Expression, Insect Expression, Cell-Free Expression, Bacterial Expression, Algal Expression, And Mammalian Expression
• By Products: Reagents, Services, Instruments, And Others
• By Application: Industrial Proteins, Cell Culture, Research, Therapeutic Proteins, Transfection Technologies & Others
• By End User: Biotechnology, Pharmaceutics, And Academia
• By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe

Regional Analysis:

Germany and Spain are the major players, while the UK is the fastest-growing market in this region. Innovative techniques are being implemented in this sector, and massive amounts are being spent on Research and Development sector in this regional market.

The protein expression market in the UK is predicted to be a lucrative region in Europe during the forecast period due to the enormous funds and investments from the UK government and other private bodies for the R&D to produce better protein expression solutions. Additionally, the technological advancements that are coming up in the UK and the well-developed healthcare infrastructure in this country are predicted to support the UK protein expression market.

Key players operating in the Europe Protein Expression Market profiled in this report are Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation.